| GC30064-500mg |
|
1799711-25-3 |
E3 ligase Ligand-Linker Conjugates 16
|
0 |
C21H23F3N4O8 |
|
|
|
| GC30064-100mg |
|
1799711-25-3 |
E3 ligase Ligand-Linker Conjugates 16
|
0 |
C21H23F3N4O8 |
|
|
|
| GC30063-100mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-50mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-25mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-10mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-5mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-1mg |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30063-10mM(1mLinDMSO) |
|
1448754-43-5 |
Eleclazine hydrochloride (GS 6615 hydrochloride)
|
0 |
C21H17ClF3N3O3 |
|
|
|
| GC30062-500mg |
|
1582-09-8 |
|
0 |
C13H16F3N3O4 |
|
|
|
| GC30062-10mM(1mLinDMSO) |
|
1582-09-8 |
|
0 |
C13H16F3N3O4 |
|
|
|
| GC30061-50mg |
|
1334179-85-9 |
|
0 |
C19H30N10O2 |
|
|
|
| GC30061-5mg |
|
1334179-85-9 |
|
0 |
C19H30N10O2 |
|
|
|
| GC30061-1mg |
|
1334179-85-9 |
|
0 |
C19H30N10O2 |
|
|
|
| GC30061-10mM(1mLinWater) |
|
1334179-85-9 |
|
0 |
C19H30N10O2 |
|
|
|
| GC30060-50mg |
|
120066-54-8 |
|
0 |
C17H28GdN4O7 |
|
|
|
| GC30060-10mM(1mLinWater) |
|
120066-54-8 |
|
0 |
C17H28GdN4O7 |
|
|
|
| GC30059-100mL |
|
9005-65-6 |
|
0 |
— |
|
|
|
| GC30058-25mg |
|
106612-94-6 |
|
0 |
C151H228N40O47 |
|
|
|
| GC30058-10mg |
|
106612-94-6 |
|
0 |
C151H228N40O47 |
|
|
|
